We are live on ! Find out more
ICM

Invenomic Capital Management Portfolio holdings

AUM $2.18B
1-Year Est. Return 0.03%
This Fund
S&P 500
This Quarter Est. Return
-8.85%
1 Year Est. Return
+0.03%
3 Year Est. Return
-6.37%
5 Year Est. Return
-25.27%
10 Year Est. Return
AUM
$1.16B
AUM Growth
-$246M
Cap. Flow
-$108M
Cap. Flow %
-9.27%
Top 10 Hldgs %
23.33%
Holding
205
New
58
Increased
35
Reduced
52
Closed
59

Top Buys

Rank Stock Value
1
ZM icon
Zoom
ZM
+$22.3M
2
VNT icon
Vontier
VNT
+$21.7M
3
SSNC icon
SS&C Technologies
SSNC
+$21.3M
4
IPGP icon
IPG Photonics
IPGP
+$21.3M
5
BKNG icon
Booking.com
BKNG
+$20.1M

Sector Composition

Rank Sector Weight
1 Technology 30.14%
2 Consumer Discretionary 16.46%
3 Communication Services 11.87%
4 Industrials 9.35%
5 Healthcare 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VMW
201
DELISTED
VMware, Inc
VMW
-134,029
Closed -$15.3M
SCU
202
DELISTED
Sculptor Capital Management, Inc. Class A Common Stock
SCU
-20,025
Closed -$167K
GER
203
DELISTED
Goldman Sachs MLP Energy Renaissance Fund
GER
-119,606
Closed -$1.33M
IS
204
DELISTED
ironSource Ltd.
IS
-7,236,859
Closed -$17.2M
GSV
205
DELISTED
Gold Standard Ventures Corp.
GSV
-1,480,795
Closed -$464K

Similar funds

Invenomic Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Invenomic Capital Management held 205 positions worth $1.16B, down 17% from $1.41B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Invenomic Capital Management withdrew a net $108M in Q3 2022, closing 59 positions and reducing 52 holdings. Its most notable exit was Cardinal Health, an estimated $17.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, Invenomic Capital Management opened a new position in Zoom worth $17.2M.

  • Invenomic Capital Management's largest Q3 2022 buy was Zoom: 234,351 shares worth $17.2M.
  • Invenomic Capital Management added most to IPG Photonics in Q3 2022, an estimated $21.3M increase.
  • Invenomic Capital Management's biggest Q3 2022 reduction was Belden, cutting an estimated $13.5M.
  • Invenomic Capital Management fully exited Cardinal Health in Q3 2022, selling an estimated $17.9M.
  • Invenomic Capital Management's ten largest holdings make up 23% of its $1.16B portfolio in Q3 2022.
  • Invenomic Capital Management opened 58 new positions and closed 59 in Q3 2022.
  • Invenomic Capital Management's portfolio value fell 17% quarter-over-quarter to $1.16B.

Based on Invenomic Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.